anayamalik, Author at European Medical Journal - Page 25 of 83

AI Tool Shows High Accuracy in Prostate Cancer Staging

A novel artificial intelligence (AI) framework called AutoRadAI has demonstrated strong diagnostic performance in detecting extracapsular extension (ECE) in prostate cancer, a key prognostic factor that can significantly impact treatment planning and surgical outcomes.

Hard-to-Treat Stroke Clots Resist Thrombectomy

Calcified cerebral emboli may significantly reduce the effectiveness of endovascular thrombectomy (EVT) and lead to worse outcomes in patients with acute ischemic stroke, according to new findings.

Air Pollution Triggers Inflammatory Stress in Male Athletes

Air pollution significantly increases inflammatory markers in outdoor athletes, particularly those with allergies, according to new research examining the immune effects of PM2.5 exposure during exercise.

Fosfomycin Offers Alternative for Drug-Resistant Prostatitis

Fosfomycin may offer a viable treatment alternative for bacterial prostatitis, particularly in patients with multidrug-resistant infections, according to a new systematic review.

Are Spondyloarthritis Diagnostic Criteria Failing Latin America?

Spondyloarthritis (SpA) classification criteria show variable diagnostic performance in Latin American populations, according to a newly published systematic review and meta-analysis.

Can Eye Drops Heal Scars? Timolol Tested After Mammoplasty

A randomized controlled trial reveals that topical timolol may offer an effective and non-invasive solution to improve the appearance of immature scars following mammoplasty surgery.

Mispriced Adverse Events Distort Cancer Drug Cost-Effectiveness

In the high-stakes landscape of cancer treatment where healthcare professionals rely on cost-effectiveness analyses to guide decisions adverse event costs may be throwing off the equation.

US Sees Growing Mortality Burden from Vascular Dementia

A new study examining vascular dementia (VaD) mortality in the United States from 2005 to 2020 reveals a marked rise in age-adjusted death rates, especially in specific regions and demographic groups.

FDA Approves Powdered Treprostinil Inhalation for Pulmonary Hypertension

THE U.S. Food and Drug Administration has approved a novel inhaled formulation of treprostinil for adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), adding a new option for improving exercise ability in these patient populations.

Lipid-Rich Emulsion Outperforms Standard Cream in Eczema Study

A new dermatology study offers compelling evidence that targeted lipid supplementation can restore the skin barrier in adults with a history of atopic dermatitis, outperforming commonly used emollients.